OCTOBER 2017 FORBES ASIA | 47JAMEL TOPPIN FOR FORBES
Incyte CEO Hervé Hoppenot counts on bleeding-edge
tech like this NMR spectrometer, used to see individual
molecules, to help his company invent new medicines.
marcin
(Marcin)
#1
OCTOBER 2017 FORBES ASIA | 47JAMEL TOPPIN FOR FORBES
Incyte CEO Hervé Hoppenot counts on bleeding-edge
tech like this NMR spectrometer, used to see individual
molecules, to help his company invent new medicines.